Hardware, Robotics & IoT VC Funds

The Amazon Industrial Innovation Fund (AIIF) is Amazon’s $1 billion venture fund focused on advancing technologies that reshape fulfillment, logistics, and supply chain sectors. Established in 2022, the fund invests in companies across various stages, from startups to established players, that bring innovative solutions to areas like warehouse automation, robotics, and artificial intelligence. AIIF's goal is to enhance Amazon’s operations, with an emphasis on employee safety, efficiency, and customer satisfaction. Under the leadership of Franziska Bossart, the fund is expanding its scope in 2024 to target additional areas such as autonomous vehicles and last-mile delivery tech. Key investments have included companies like Agility Robotics, which develops bi-pedal robots for warehouse operations, and Vimaan, specializing in computer vision for inventory management. AIIF’s investments in companies such as Modjoul, which creates wearable safety devices, highlight its commitment to fostering technologies that support workplace safety while advancing automation. AIIF aims to support high-quality companies globally, not limited to Amazon's internal needs, as it seeks broader improvements in industrial automation and supply chain management. This makes AIIF a significant player in the field of corporate venture capital, uniquely positioned to drive impactful innovations while improving Amazon’s logistics capabilities and operational safety.

AMCREF Community Capital is an impact-driven finance firm based in New Orleans, specializing in providing flexible, below-market-rate financing to businesses that generate significant environmental, social, and economic benefits. Founded in 2005, AMCREF primarily supports companies in low-income and rural communities across the Southern U.S., with a focus on industries like clean energy, sustainable manufacturing, recycling, and green infrastructure. AMCREF has deployed over $650 million in New Markets Tax Credits (NMTC), a federal program aimed at stimulating economic growth in underserved areas. These funds are used to support startups and high-growth companies that align with AMCREF's mission of job creation, environmental sustainability, and community development​. With a strong leadership team including co-founders Knox Clark and Clifford Kenwood, AMCREF brings over 25 years of expertise in specialty finance, tax credit programs, and community development​. They target industries such as green manufacturing, sustainable forestry, and efficiency improvements, leveraging both federal and state tax credits to maximize impact.

AME Cloud Ventures, founded by Yahoo! co-founder Jerry Yang, is a leading venture capital firm investing in data-driven companies. Notable investments include Zoom, Wish, Zymergen, Planet, and Freenome. The firm focuses on tech-heavy industries, particularly those involved in data infrastructure, applications, mobile, and sensors. AME Cloud Ventures operates globally with a strong emphasis on U.S. and China-based companies. Their strategy is to back visionary entrepreneurs, providing not just capital but also strategic guidance and a vast network of mentors and international partners. Their typical check size ranges from $2 million to $10 million for early-stage investments, with larger sums for later stages. They are known for their active role in portfolio companies, offering operational support and leveraging industry connections to foster growth and innovation. Key team members include Jerry Yang and Jeff Chung, who focus on empowering big thinkers and frontier technologies. The team, based in Palo Alto, California, includes experts in various fields such as manufacturing, biology, and intelligent robotics. Startups looking to engage with AME Cloud Ventures should seek introductions through their network and highlight how their innovative use of data aligns with AME's strategic vision. This, along with a strong business model and growth potential, increases the likelihood of securing investment from this influential fund

American Express, through its venture capital arm Amex Ventures, plays an active role in investing in innovative startups that align with its core business. Launched in 2011, Amex Ventures primarily focuses on companies developing cutting-edge technologies in sectors such as financial services, e-commerce, cybersecurity, and digital payments. The firm’s investment strategy centers around supporting companies that can help enhance and expand American Express's offerings, improve customer experience, and drive growth in key markets. Amex Ventures invests in early-stage to growth-stage startups that have the potential to shape the future of commerce. The venture arm has backed numerous successful companies, including Plaid, Stripe, Bill.com, and Trulioo, highlighting its emphasis on financial technology and innovation. By partnering with these startups, American Express gains access to new technologies that help improve its cardholder services, payment infrastructure, and digital offerings. In addition to providing capital, Amex Ventures offers its portfolio companies strategic guidance and access to its vast network of partners and customers. This allows startups to benefit from the global reach and resources of American Express while accelerating their own growth. The venture arm is integral to the company’s broader mission of remaining at the forefront of digital innovation in the financial industry. By fostering strong relationships with innovative startups, Amex Ventures helps American Express stay competitive in an evolving digital landscape, while also supporting the development of transformative technologies.

Amino Capital, based in Palo Alto, is a global venture capital firm focused on seed to growth-stage investments, with a particular emphasis on data-driven startups and technologies that create network effects. Founded by Larry Li, the firm manages over $1 billion in assets and has invested in a diverse array of sectors including Consumer Tech, PLG SaaS, Frontier Tech, AI, and Web3. Amino Capital's portfolio boasts over 200 companies, with notable investments in Chime, Webflow, Rippling, Grail, Weee!, Replit, and Turing. They have a track record of successful exits, with 25 exits and 17 companies achieving unicorn status. Their investment strategy centers on leveraging data moats to create sustainable competitive advantages for their portfolio companies. The firm is geographically focused primarily on the US, China, and parts of Europe, reflecting a broad international investment strategy. Their team, led by Larry Li and other experienced partners, provides significant value-add through strategic guidance, operational support, and extensive industry connections. For startups looking to engage with Amino Capital, the key is to demonstrate how their technology leverages data to create substantial network effects and competitive advantages. The firm looks for resilient and adaptable teams that can thrive in rapidly evolving tech environments. Larry Li, a former entrepreneur himself, emphasizes the importance of energetic and reflective teams in driving innovation.

Amiti Ventures is a prominent deep-tech seed-stage VC firm based in Israel, known for investing in transformational technologies that promise to reshape industries. Amiti focuses on early-stage companies developing innovations in sectors such as AI, semiconductors, computational biology, quantum computing, and cybersecurity. Their portfolio includes companies like Innoviz, a leader in autonomous vehicle LiDAR technology, and Vayyar Imaging, which has expanded its groundbreaking radar tech across healthcare and automotive markets. Amiti’s investment strategy is forward-looking, targeting disruptive technologies that are years ahead of market trends. They are patient investors, often backing technologies that require long development cycles. They take a hands-on approach, supporting founders not just with capital but with strategic advice, business development, and their extensive global network. The firm predominantly invests in Israeli startups, leveraging Israel’s tech talent to identify world-class founders. Founders can expect personalized support through Amiti’s strong community and partnership network, and they actively promote diversity in their portfolio. Amiti also runs a “Nurture” program, designed to help tech innovators transition into entrepreneurship by providing foundational knowledge and access to a broader support network. Led by Ben Rabinowitz and a diverse team, Amiti offers significant value beyond financial investment, helping companies navigate the challenges of scaling cutting-edge technologies. They frequently lead funding rounds and remain deeply engaged with their portfolio companies, ensuring a balance between long-term vision and strategic execution.

Amity Ventures is a San Francisco-based venture capital firm that focuses on supporting founders in building category-defining businesses. Founded in 2016, the firm is committed to partnering with a select few startups, providing them with the necessary resources and guidance to scale effectively. The team at Amity Ventures includes experienced investors like Patrick Yang, a co-founder and general partner, and Peter Bell, a senior advisor with a notable history in early-stage investments and entrepreneurship. Amity Ventures' portfolio features a range of innovative companies across various sectors, including cybersecurity, contract management, communication software, and sales commissions management. Notable portfolio companies include Snyk, an application security provider; Evisort, an AI-powered contract management platform; Talkdesk, a cloud contact center solution; and CaptivateIQ, a sales commissions management platform. The firm emphasizes a collaborative approach, working closely with founders to help them build impactful technologies and scale their businesses. Their investment strategy focuses on early-stage technology companies, particularly those leveraging automation as a transformative force in their industries

Amplify Partners, founded in 2012 and headquartered in Menlo Park, California, is a venture capital firm specializing in early-stage investments. The firm focuses on areas such as information technology, machine intelligence, infrastructure, and developer tools, supporting technical founders building the next generation of applications and platforms. Amplify Partners has a notable portfolio, including investments in companies like Datadog, a leader in cloud monitoring and security; Fastly, a real-time content delivery network; and Scribe, which automates the documentation of processes. They have also invested in emerging startups such as Meroxa, a data streaming platform, and Metaphor, a search and discovery tool for data scientists. The firm has made over 258 investments, demonstrating a strong track record of identifying and nurturing innovative tech companies. Amplify Partners is also known for its significant exits, including Intellimize and Minerva Labs. Their investment approach combines providing capital with deep operational support, leveraging their extensive industry experience to help portfolio companies scale effectively. Amplify Partners recently expanded their Amplify Select Fund to $200 million, emphasizing their commitment to supporting their portfolio companies through various growth stages and into the public markets. This expansion allows them to double down on their most promising investments, ensuring sustained growth and success for their portfolio companies.

Amplify.LA, based in Los Angeles, is a pre-seed venture capital firm dedicated to supporting early-stage technology startups in the region. Founded in 2011, the firm has made over 150 investments and focuses on sectors such as enterprise software, fintech, consumer products, and healthtech. Notable investments in Amplify.LA’s portfolio include FloQast, an accounting workflow automation platform; Upwards, a technology-driven care solutions company; and Penelope, a retirement platform for small businesses. The firm has also seen successful exits, such as the acquisition of Lensabl, a direct-to-consumer optical company, and Clutter, a moving and storage service. Amplify.LA is known for its hands-on approach, providing not only capital but also strategic guidance and support to help startups grow and scale effectively. The team, led by co-founders Paul Bricault, Oded Noy, and others, leverages their extensive network and industry experience to drive the success of their portfolio companies.

Amplifyher Ventures, founded in 2018 and based in New York City, is a venture capital firm dedicated to investing in early-stage startups led by exceptional women. The fund's mission is to bridge the gender gap in leadership roles by supporting female founders and fostering diversity within the entrepreneurial ecosystem. Key investments include companies like Copper Cow Coffee, Expressable, and Summersalt, showcasing their focus on consumer products, e-commerce, and health tech. The firm emphasizes industries such as commerce, care, and connectivity, seeking out businesses that leverage community-driven marketing for exponential growth. Amplifyher Ventures typically invests in pre-seed, seed, and Series A rounds, with an average investment size of $2 million. Their strategic approach involves not just financial support but also leveraging their extensive network and marketing expertise to help startups scale efficiently without relying heavily on traditional advertising platforms like Facebook and Google. The team is led by Tricia Black, a seasoned venture capitalist with a background in high-growth business roles, and Meghan Cross, a former startup marketer and experienced VC. Both are based in New York and bring a wealth of experience in identifying and nurturing high-potential ventures. Amplifyher Ventures is known for its hands-on approach, actively engaging with portfolio companies to provide mentorship and strategic advice, thereby maximizing their chances of success​.

Amplitude Ventures is a Montreal-based venture capital firm, founded in 2018, that focuses on precision medicine, investing at the intersection of biology and AI. The firm aims to support and scale companies that drive significant advancements in healthcare, particularly within Canada's innovation-rich ecosystem. Notable investments include Zymeworks, a biopharmaceutical company specializing in protein therapeutics, which went public in 2017, and Milestone Pharmaceuticals, known for its treatment for cardiovascular conditions, which also went public in 2019. Other key investments are DrugBank, a comprehensive drug database, and Valence Labs, which was acquired by Recursion. Amplitude Ventures recently closed a $263 million fund, significantly enhancing their capacity to invest in and grow cutting-edge precision medicine companies. The firm operates with a hands-on approach, providing strategic guidance and leveraging a strong network of industry experts. The leadership team includes co-founders Dion Madsen, Jean-François Pariseau, and Bharat Srinivasa, who bring extensive experience in life sciences and venture capital, ensuring robust support for their portfolio companies.

Amplo, founded in 2017 and headquartered in Spring, Texas, is a global venture capital firm that invests in early-stage startups across various sectors, including financial technology, artificial intelligence, healthcare, and software. The firm has built an impressive portfolio with notable companies such as Robinhood, Parsley Health, and 1Concern. Amplo has successfully supported eight unicorns, including Genies, Ironclad, and TravelPerk, highlighting its strategic investment approach. The firm emphasizes backing companies that aim to create meaningful societal impact, reflecting its commitment to innovation and positive change. Recent investments include Crosby Health and Two Chairs, which focus on health tech and healthcare services, respectively. The team at Amplo is led by Sheel Tyle, the founder and CEO, and consists of experienced professionals dedicated to providing strategic support and resources to their portfolio companies.

Ananda Impact Ventures, established in 2009, is a leading European venture capital firm dedicated to impact investing. The firm operates primarily in the DACH region, the UK, Benelux, and Scandinavia, focusing on early-stage investments from Seed to Series A rounds. Ananda manages around €200 million in assets across multiple funds, including their latest €108 million fund launched in 2023. Ananda invests in companies that address significant social and environmental challenges, aligning their business models with the UN’s Sustainable Development Goals. Their portfolio includes companies like OroraTech, which uses satellite technology to monitor wildfires, and NatureMetrics, which provides biodiversity data solutions through eDNA technology. The firm's investment strategy is built on their unique Impact Termsheet, which ties financial success to measurable impact outcomes. This model ensures that the impact is integral to the business, fostering long-term sustainability and growth. Ananda also emphasizes diversity and founder health, supporting entrepreneurs with robust resources and a hands-on approach to partnership. Founders appreciate Ananda's supportive and mission-aligned investment approach, which combines financial backing with strategic guidance to help scale impactful innovations. The firm prides itself on its deep commitment to creating positive societal change through venture capital.

Anchor Capital GP, founded in 2019 and based in Dallas, Texas, is a venture capital firm that provides advisory services and investment capital for disruptive startups. The firm focuses on high-growth sectors like FinTech, PropTech, ClimateTech, and AdTech, with investments spanning from seed to Series D stages. Their portfolio includes notable companies like Prizeout, Nom Nom, and Plant Prefab, showcasing their interest in innovative businesses across industries. Anchor Capital GP’s approach leverages a robust network of private investors, family offices, and institutional partners to help startups scale globally. With 14 investments and 3 successful exits, the firm is actively involved in guiding startups through growth phases by providing capital, expertise, and strategic partnerships. They prioritize hands-on involvement, working closely with founders to ensure their companies succeed in the modern economy

Andera Partners, established in 2001 and headquartered in Paris, is a prominent private equity firm specializing in investments in life sciences, growth capital, and buyouts. The firm has built a strong reputation for its expertise in supporting companies at various development stages, particularly within the biotech and medical technology sectors. One of Andera's flagship initiatives is the BioDiscovery fund family, which has collectively raised over €1.1 billion to date. Their latest fund, BioDiscovery 6, closed at €456 million, highlighting significant investor confidence. This fund targets innovative therapeutic products and medical technologies, investing in companies across Europe and the United States. Notable investments include companies like Evommune, Amolyt, and TargED. Andera Partners employs a hands-on approach, providing both financial and strategic support to its portfolio companies. The firm's life sciences team, comprising experienced professionals like Sofia Ioannidou, Olivier Litzka, and Gilles Nobécourt, plays a crucial role in guiding startups from the preclinical stages to commercialization. Their strategic partnerships and extensive network bolster their ability to support high-potential innovations.

Andreessen Horowitz (a16z), headquartered in Menlo Park, California, is a premier venture capital firm known for its significant impact on the tech industry. Founded in 2009 by Marc Andreessen and Ben Horowitz, the firm has invested in high-profile startups such as Facebook, Airbnb, GitHub, and Coinbase. Their portfolio boasts a diverse range of industries, including AI, biotech, fintech, and consumer tech. A16z has a unique approach to investing, combining capital with extensive support. Their investments range from seed to late-stage funding, with recent high-profile investments including Mistral AI and Pinecone. They actively support their portfolio companies through a robust ecosystem of resources, including a market development team, operating partners, and a talent network​​. The firm is also heavily involved in emerging technologies, particularly in the cryptocurrency and blockchain space. They have launched dedicated funds for crypto investments and established initiatives like the a16z Crypto School to educate and support founders in this domain. Furthermore, their Cultural Leadership Fund aims to enhance diversity and inclusion in the tech industry​​. For founders, a16z's focus on innovation and long-term support makes them an attractive partner. They value visionary, dedicated founders and look for startups with significant market potential and disruptive capabilities. This holistic support strategy sets a16z apart, offering more than just financial investment but also strategic guidance and network access to help startups thrive.

Angeleno Group, founded in 2001 and based in Los Angeles, is a venture capital firm specializing in growth capital for next-generation clean energy and climate solutions companies. With a strategic focus on sectors such as renewable energy, energy storage, sustainable mobility, and carbon mitigation, Angeleno Group aims to address critical global challenges posed by climate change. The firm leverages its extensive industry experience and longstanding relationships to support high-growth, innovative businesses. Angeleno Group invests opportunistically, typically deploying between $10 million and $30 million per opportunity, and focuses on companies with proven technologies and established customer traction. Their portfolio includes a diverse array of companies such as Fictiv, Span, and Anza RE, highlighting their commitment to fostering sustainable and transformative technologies. Angeleno Group's investment strategy is deeply rooted in creating value through active engagement with portfolio companies, providing support in product development, business strategy, sales, and corporate finance. The firm's approach is sector-focused, research-driven, and designed to build a diversified and high-return portfolio.

Angels Santé, established in 2008 and based in Paris, is the largest healthcare-focused business angel network in Europe. It supports early-stage startups in the Biotech, Medtech, and Digital Health sectors, helping bring innovative solutions to market that benefit patients. With over 100 investments made since its inception, the organization fosters partnerships between entrepreneurs and healthcare professionals, providing not only capital but also deep industry expertise in clinical, regulatory, and scientific domains. Each year, Angels Santé finances 10-15 deals, with a focus on Europe, but its reach extends globally through partnerships with organizations like EBAN and Business Angels Europe. This international collaboration allows Angels Santé to facilitate cross-border investments and provide startups with access to a broader market. The network emphasizes a hands-on approach, guiding startups through the complexities of the healthcare landscape by offering mentorship and connections to relevant stakeholders. Notable figures such as Eric Garnier, the president, emphasize the critical role that healthcare innovation plays in solving modern challenges. Furthermore, their US branch, based in Boston, extends opportunities for French-speaking investors in the United States to support healthcare startups with global aspirations. Angels Santé is not just about funding; it's about building a community dedicated to advancing healthcare through innovation, with a long-term commitment to improving patient outcomes and supporting the growth of impactful healthcare companies.

AngelsDeck is a global venture capital network that operates through a unique club model, connecting investors and startups for syndicated investment deals. Founded with the mission to create an international ecosystem for venture deal syndication, AngelsDeck has established itself as a key player in supporting early-stage startups across a variety of industries. With over 14 chapters worldwide and 500 active members, AngelsDeck provides a platform for investors to co-invest in high-growth startups from regions including the US, Europe, the Middle East, and Asia. The firm focuses primarily on seed to pre-Series B companies, with a keen interest in sectors such as technology, healthcare, and sustainability. By leveraging its network of investors, AngelsDeck facilitates joint investments that allow startups to scale quickly while benefiting from strategic mentorship and financial backing. AngelsDeck also runs a startup bootcamp, providing early-stage companies with access to investors and resources to accelerate their growth. One of the unique aspects of AngelsDeck is its ability to create an exclusive and collaborative investment community, where deals are syndicated across its global chapters. This enables investors to pool resources and expertise, speeding up the funding process for startups. AngelsDeck’s investment model emphasizes long-term growth and market expansion, with a clear focus on supporting innovative startups with the potential to disrupt industries.

Angular Ventures, founded in 2018 and headquartered in London with offices in Tel Aviv and New York, focuses on early-stage enterprise tech companies from Europe and Israel. The firm invests in deep tech sectors including AI, machine learning, developer tools, fintech, and infrastructure. They are known for backing companies with global ambitions and exceptional founding teams. Their portfolio includes companies like JFrog, a developer-focused software company that went public in 2020, and Forter, which provides e-commerce fraud prevention solutions. Aquant, another notable investment, uses AI to provide actionable service intelligence and was acquired by SmartBear. Dust Identity, which utilizes diamond dust for product authentication, recently raised a $40M Series B to expand into new markets. Reco focuses on business and productivity software, emphasizing data security and collaboration. Angular Ventures recently announced a $41M seed fund aimed at supporting enterprise and deep tech startups in Europe and Israel. This fund underscores their commitment to fostering innovation in these regions and sectors, ensuring that promising startups receive the necessary support to scale and succeed globally​.

Animal Capital, founded in 2020 and based in New York, is a venture capital firm that focuses on investments in consumer technology, financial technology, health and wellness, and media sectors. This firm is distinguished by its unique approach, leveraging the influence of its founders, who are prominent social media stars such as Josh Richards, Griffin Johnson, and Noah Beck, to drive consumer awareness and engagement for its portfolio companies. Notable investments by Animal Capital include Breakr, a platform connecting artists with influencers; Step, a banking app aimed at helping teenagers build credit and learn financial literacy; and Super Coffee, a sugar-free, enhanced coffee brand. Other significant investments include Colossal Laboratories & Biosciences, which focuses on biotechnology, and Zurp, a social platform software company. Animal Capital's strategy involves providing traditional venture capital services such as fundraising and scaling companies, alongside leveraging the founders' broad networks and influence to impact consumer purchasing decisions. This Gen Z-focused approach aims to set new standards in the investment space by effectively tapping into the purchasing power and cultural influence of younger generations.

Animo Ventures is a venture capital firm dedicated to backing early-stage founders who are passionate and willing to go all in. Based in Miami with additional offices in New York and San Francisco, Animo focuses on pre-seed and seed investments in the U.S., cutting checks that range from $500,000 to $2.5 million. The firm actively invests in sectors like fintech, enterprise software, digital health, B2B, and consumer-facing technology, aiming to nurture high-growth startups from ideation to early traction​. What sets Animo apart is its radically founder-focused approach. The firm operates without layers of analysts or associates, meaning founders work directly with general partners throughout the investment process. The team, led by Nico Berardi and Antonio Osio, is deeply involved in all aspects of the startups they back, offering not only capital but also strategic guidance. Animo reserves a significant portion of its fund for follow-on investments, ensuring long-term support​. Animo’s portfolio includes notable companies such as Nearpod, Intello, Morty, and Ironclad, with a particular focus on fintech and enterprise SaaS. The firm is not only a financial backer but also acts as a strategic partner, leveraging a dense network of connections to help with fundraising, hiring, and scaling. With its "people backing people" ethos, Animo builds genuine, long-term relationships with founders, committed to seeing them succeed through every challenge and milestone​.

Ankur Capital is an early-stage venture capital firm based in India, specializing in transformative technologies targeting the next billion people. Founded with a mission to support innovative business models addressing core challenges in sectors such as agriculture, healthcare, education, and fintech, Ankur Capital invests in both digital technology and deep science technology-led companies. Their portfolio includes companies like Cropin, which is driving smart farming; Niramai, pioneering early breast cancer detection with AI; and StringBio, which converts greenhouse gases into value-added proteins. Ankur Capital is dedicated to creating impact through responsible agriculture, climate mitigation and adaptation, and inclusive growth. The firm emphasizes hands-on support, working closely with entrepreneurs from seed to scale. Through their in-house platform, AnkurGro, they provide strategic guidance and operational assistance to help founders navigate their growth journey.

Anorak Ventures, founded in 2016 and headquartered in San Francisco, is a seed-stage venture firm that focuses on investing in transformative technology and people. The firm primarily invests in pre-seed and seed-stage companies across various technology sectors, including artificial intelligence and machine learning (AI/ML), Internet of Things (IoT), robotics, and consumer tech. Anorak Ventures has invested in over 120 seed-stage technology companies, which now represent an aggregate market capitalization of $24.8 billion. Notable investments in their portfolio include companies such as Vantage Point, WeatherCheck, Orderful, Framework, Prisms VR, Better Health, and Marxent. They are dedicated to helping these companies achieve product-market fit and secure follow-on financing. The firm, led by Managing Partner Greg Castle, aims to support innovative startups by providing not just capital but also strategic guidance to help them scale and succeed in competitive markets​.

ANRI is a venture capital firm based in Tokyo, Japan, focusing primarily on seed and early-stage investments. Founded with the mission to drive innovation, ANRI has invested in over 260 companies, emphasizing sectors such as electric vehicles, recycling, manufacturing, and information technology. Notable investments by ANRI include startups like Turing, a manufacturer in the electric vehicle sector, and amu, which focuses on recycling and waste management. Their portfolio showcases a strong commitment to diverse industries, including health tech and fintech. ANRI's investment approach often involves co-investing with other significant players in the market, thereby enhancing their portfolio companies' growth and market reach. ANRI has successfully achieved exits with companies like Raksul, DELY, and Coincheck, highlighting their capability to nurture startups towards profitable outcomes. Their investment philosophy emphasizes supporting innovative ideas that have the potential to make substantial impacts globally. The firm is also committed to diversity and inclusion, having set and achieved goals to increase investments in startups led by women. This dedication to fostering a diverse entrepreneurial ecosystem is part of ANRI's broader strategy to drive meaningful change and innovation in the startup landscape​.

Anterra Capital is a venture capital firm that specializes in investments within the food and agricultural technology sectors. Founded in 2013, Anterra Capital has offices in Amsterdam and Boston and focuses on backing innovative companies that address critical challenges in agriculture, food production, and sustainability. Their portfolio includes notable investments such as Enko Chem, which develops novel crop protection products; ProducePay, a financial and data services platform for the fresh produce industry; and BiomEdit, which focuses on microbiome innovation for animal health. The firm manages over $450 million in assets and typically invests in Series A or B rounds, with initial checks ranging from $1 to $10 million. Anterra is committed to leveraging biotechnology and digital solutions to transform the food system, improve consumer health, and enhance the livelihoods of farmers. Their investment strategy emphasizes impact and sustainability, aligning with their goal to create a resilient and sustainable food system. Anterra Capital has raised significant funds, including a $260 million second Global Food and Agriculture Technology Fund, which continues to support biotech and digital innovations in the agrifood sector​.

Anthemis Group, founded in 2010 and headquartered in London, is a global investment platform dedicated to fostering innovation in the financial system. The firm focuses on fintech, insurtech, and related sectors, investing from seed to growth stages. Anthemis' portfolio includes notable companies such as Betterment, eToro, and Currencycloud. They also back innovative startups like Pipe, Weavr, and Atomic. With over 150 investments worldwide, Anthemis emphasizes diversity and inclusivity, with 23% of their portfolio companies founded by women and 40% led by women or BIPOC. Their commitment to diversity is further demonstrated through the Female Innovators Lab, which supports female founders in fintech across the UK and Europe. Anthemis recently closed multiple funds totaling over $700 million, expanding their support for fintech companies throughout their lifecycle. The firm also launched an ESG-focused SPAC to advance sustainable finance. Anthemis' thesis-driven approach leverages deep market insights to drive systemic, long-term change. Led by founder Amy Nauiokas and CEO Briana van Strijp, Anthemis is poised to continue its mission of reinventing finance through innovation, collaboration, and inclusivity, supporting the next wave of fintech innovation globally.

Anthos Capital, founded in 2007 and based in Santa Monica, California, focuses on growth-stage investments in consumer products, technology, healthcare, and financial services sectors. The firm has made notable investments in companies like Carbon Robotics, known for its Autonomous Weeder which helps reduce reliance on herbicides, and Todyl, a comprehensive cybersecurity platform aimed at small and mid-market businesses. Anthos Capital takes a strategic partnership approach, providing not just capital but also operational and strategic support to help portfolio companies grow and lead their industries. They focus on investments that promise significant growth and impact, supporting companies from early to growth stages with tailored assistance. The firm's recent investment activities include significant funding rounds for companies like Carbon Robotics and Todyl, reflecting their commitment to fostering innovation and industry leadership. Their portfolio showcases a diverse range of companies, emphasizing Anthos Capital's ability to identify and nurture high-potential ventures across various sectors.

Anthro Ventures is an early-stage venture capital firm focused on transforming healthcare and life sciences. The fund aims to improve patient outcomes while simultaneously reducing healthcare costs by investing in innovative, cutting-edge technologies. Anthro Ventures has made notable investments in companies such as Hannah Life Technologies and Ride Health, which align with their goal of addressing unmet clinical needs. Their investment strategy targets early-stage companies—primarily in pre-seed, seed, and Series A rounds. They focus on startups developing impactful medical devices, diagnostics, and digital health solutions. Geographically, their investments span both the U.S. and international markets, including regions like Singapore. Led by managing director Martin Akhavan, Anthro Ventures offers a hands-on approach, guiding their portfolio companies through growth and market dynamics. They tend to favor companies that present a clear path to scalability and that align with their mission of "humanizing healthcare." Startups looking to partner with Anthro should demonstrate both technological innovation and a strong potential to drive down healthcare costs.

Antler is a globally renowned early-stage venture capital firm known as the "day zero investor," backing founders from the inception of their startups. With over 850 investments in 20+ countries, Antler has notable portfolio companies like Airalo, a global eSIM provider, and has recently raised a $60 million MENAP fund to further support startups in the Middle East, North Africa, and Pakistan region. Antler focuses on sectors including technology, fintech, and digital innovation, providing personalized coaching, co-founder matching, and follow-on funding. Key team members include Dr. Jonathan Doerr and Romain Assunção, leading regional activities from Riyadh and Duba

Anzu Partners is a venture capital firm founded in 2014, focusing on breakthrough industrial and life sciences technologies. Headquartered in Washington, D.C., with additional offices in Boston, San Diego, and Tampa, the firm manages over $1 billion in strategic assets across various funds and investment strategies. Anzu Partners has a robust portfolio of around 40 companies, including notable investments in e-Zinc, Framework, EnCharge, AM Batteries, and Arduino. The firm has also achieved significant exits, such as NUBURU and Ai-Media, highlighting its capability to support companies from early stages through to successful public offerings or acquisitions. Anzu specializes in three primary investment solutions: venture capital investments, debt and revenue-based investments, and Special Purpose Acquisition Companies (SPACs). The firm provides not just capital but also deep expertise in business development, market positioning, global connectivity, and operations, helping to drive the commercial success of its portfolio companies. The leadership team at Anzu Partners includes experienced professionals like Managing Partners David Michael, David Seldin, and Whitney Haring-Smith, who bring decades of combined experience in global investments and consultancy. This expertise is further supported by a dedicated team of technical and operational professionals.

Apax Partners is a leading global private equity advisory firm with a focus on inspiring growth and transforming businesses. Founded nearly 50 years ago, Apax has raised and advised over 30 funds, managing more than $77 billion in aggregate capital. The firm primarily invests in four sectors: Tech, Services, Healthcare, and Internet/Consumer. Apax operates several strategic funds, including Apax Global Buyout, which focuses on transformative growth in key sectors, and Apax Digital Growth, aimed at accelerating tech companies. Additionally, Apax Global Impact targets companies that deliver tangible societal and environmental benefits, while Apax Mid-Market Israel leverages local expertise to support growth in Israeli businesses. The firm also has Apax Credit and Apax Listed Private Equity strategies to provide a flexible investment approach across the capital structure​. Notable investments include Auto Trader Group, GlobalLogic, and Cole Haan, among others. Apax leverages its deep sector expertise and global network to drive operational excellence and digital transformation within its portfolio companies. The firm’s extensive experience and strategic focus have made it a prominent player in private equity globally, with offices in major financial hubs including London, New York, Hong Kong, and Tel Aviv​.

APEX Ventures is a venture capital firm based in Vienna, Austria, specializing in deep tech and medical technology startups. Founded in 2016, APEX Ventures invests in early-stage companies across Europe, with a focus on innovations in AI, quantum computing, automation, robotics, computer vision, space technology, and medical technology. The firm emphasizes backing startups with unique, defensible technologies that have the potential to disrupt and transform their respective industries​. In 2023, APEX Ventures partnered with Amadeus Capital Partners to launch the Amadeus APEX Technology Fund, which aims to raise €80 million to support deep tech startups primarily in the DACH region (Germany, Austria, and Switzerland). This fund focuses on seed and Series A investments, typically ranging from €1 million to €1.5 million. The partnership combines APEX’s local expertise and network with Amadeus’ extensive global experience in venture capital. APEX Ventures has a diverse portfolio, including companies like contextflow, ImageBiopsy Lab, and Mobius Labs. The firm is known for providing not just capital but also strategic support, leveraging their deep tech expertise and strong networks to help startups scale and succeed​.

Apollo Global Management, a leading global alternative investment manager, has a diverse and extensive portfolio across various sectors. As of 2024, Apollo manages approximately $548 billion in assets, with substantial investments in private equity, credit, and real estate. In the private equity space, Apollo's portfolio includes companies like ADT Inc., a major provider of security and automation solutions; CareerBuilder, an online employment service; and The Fresh Market, a specialty grocery retailer. They also have significant holdings in the healthcare sector with companies like LifePoint Health and R1 RCM Inc. Apollo is known for its strategic acquisitions across multiple industries. Notable recent acquisitions include U.S. Silica, a producer and supplier of silica sand, and Modern Aviation, a premium aviation services provider. Additionally, Apollo has made significant investments in the travel and hospitality sector, exemplified by its acquisition of Great Wolf Resorts and Diamond Resorts International. The firm's investment strategy focuses on creating value through buyouts, corporate carve-outs, and distressed asset investments. This approach has enabled Apollo to build a robust portfolio that spans various geographies, primarily the United States and the United Kingdom, with a strong presence in the energy and financial services sectors.

Apollo Projects, spearheaded by the Altman brothers—Sam, Jack, and Max—is a venture capital firm that specializes in funding transformative, early-stage companies. With a focus on "moonshots," Apollo targets startups with the potential to disrupt industries and create significant societal impact. Their portfolio boasts notable investments like KoBold Metals, which uses artificial intelligence for mineral exploration, and Glydways, a revolutionary transportation company. Apollo Projects is particularly active in sectors such as AI, renewable energy, and advanced biotechnology, where innovation can drive profound change. The firm typically leads funding rounds, writing substantial checks to support the ambitious goals of its portfolio companies. Apollo's investment strategy is centered around identifying and nurturing startups that are not only innovative but also have a clear vision for large-scale impact. They are especially interested in companies that challenge the status quo and push the boundaries of technology and industry norms. With a seasoned team led by the Altman brothers—each bringing a wealth of experience from their diverse backgrounds—Apollo Projects offers more than just capital. They provide strategic guidance and a deep network of industry connections, making them an invaluable partner for startups aiming to scale quickly and effectively. Entrepreneurs with bold, disruptive ideas often find Apollo Projects to be an ideal ally in their journey to bring groundbreaking technologies to market. This combination of financial backing, expertise, and a shared vision for the future positions Apollo Projects as a pivotal force in the venture capital landscape.

Apollo Health Ventures is a transatlantic venture capital firm with offices in Berlin and Boston, focusing on biotechnology and health tech ventures aimed at extending human healthspan. Established in 2016, Apollo specializes in seed and early-stage investments, particularly in companies that target aging-related diseases and conditions. Their investments focus on developing technologies and therapeutics that address the root causes of aging, helping to maintain cellular health, reduce chronic inflammation, and strengthen the immune system. In 2021, Apollo closed its second fund at $180 million, supported by both existing and new investors. This fund is designed to build and invest in data-driven companies developing breakthrough treatments for age-related diseases. Apollo has co-founded several pioneering companies, including Samsara Therapeutics, which develops autophagy-enhancing molecules, and Aeovian Pharmaceuticals, which focuses on therapeutics to extend healthspan. The firm is led by a team of experienced biotech investors and entrepreneurs, including co-founder Nils Regge, whose ventures have raised over $1 billion in capital. The team also includes Dr. Jens Eckstein, a seasoned venture capitalist with a history of successful biotech investments, and Dr. Marianne Mertens, who brings extensive experience from life sciences and venture investing. With its unique focus on longevity and aging-related innovation, Apollo Health Ventures is at the forefront of biotech ventures aiming to transform healthcare.

Apple Tree Partners (ATP) is a distinguished venture capital firm focused on life sciences, founded in 1999 by Dr. Seth Harrison. With offices in New York, San Francisco, and Cambridge, ATP has committed $2.9 billion in capital, making it one of the key players in biotech venture investing. The firm’s approach is unique in that it both creates and invests in companies, often starting from early-stage scientific ideas or asset spinouts from other companies. ATP provides flexible capital and strategic support to foster the development of science-driven enterprises. The firm is involved in every stage of a company’s life cycle, from seed investments to IPO and beyond. Notably, ATP has been instrumental in launching over 30 life sciences companies, of which 19 have gone public or been acquired. Some successful portfolio companies include Chinook Therapeutics, Akero Therapeutics, and Stoke Therapeutics​. In addition to financial backing, ATP brings operational expertise to its portfolio companies, helping them navigate clinical trials, regulatory processes, and market entry strategies. The firm has pioneered advancements in fields such as oncology, metabolic diseases, and inflammatory disorders, combining deep scientific understanding with entrepreneurial rigor. ATP’s investments, including its recent creation of Deep Apple Therapeutics, exemplify its commitment to using cutting-edge technologies like AI and machine learning to accelerate drug discovery and deliver life-changing therapies.

Applied Ventures is the venture capital arm of Applied Materials, based in Santa Clara, California. Since its establishment in 2006, the firm has focused on early-stage investments, primarily within deep technology sectors such as semiconductors, energy, advanced materials, and life sciences. Applied Ventures has a global reach, with investments spanning across North America, Europe, Asia-Pacific, and the Middle East. The firm is known for its flexibility, investing up to $100 million annually and actively participating in funding rounds ranging from $10 to $50 million. Its strategy emphasizes supporting startups with disruptive technologies by connecting them to Applied Materials' global ecosystem, which includes industry partners, supply chain resources, and technical expertise. Key portfolio companies include Ayar Labs (optical I/O technology), Rockley Photonics, and TXOne Networks, reflecting its focus on innovations that align with Applied Materials' core strengths in materials engineering and semiconductor technology​. The investment team is led by Anand Kamannavar, who serves as Global Head, alongside key figures such as Brad McManus, John Wei, and Rajesh Ramanujam, all based in Santa Clara. Applied Ventures is stage-agnostic, supporting both early and growth-stage startups as they scale globally, especially those involved in deep tech advancements.

Apposite Capital is a London-based venture capital firm specializing in the healthcare sector. Founded in 2006, the firm focuses on investing in innovative healthcare companies across the UK and Europe. Apposite Capital provides a mix of venture, development, and growth financing, along with buyout capital, primarily targeting companies that can significantly impact healthcare through improved services and technologies. Their investment strategy emphasizes supporting companies with scalable business models and strong growth potential. Apposite Capital has a track record of successful investments in healthcare services, medical devices, diagnostics, and digital health. The firm typically takes an active role in its portfolio companies, providing strategic guidance and leveraging its extensive network within the healthcare industry to drive growth and innovation. Apposite Capital's team brings a combination of operational, scientific, and financial expertise, allowing them to deeply understand and support the unique needs of healthcare businesses. They also focus on promoting best practices in environmental, social, and governance (ESG) and are committed to making a positive impact through their investments. Recent notable investments include companies like NIMGenetics, HCML, and Emblation, showcasing their commitment to advancing healthcare solutions and improving patient outcomes​.

APX is a Berlin-based venture capital firm that focuses on pre-seed investments, supporting startups at the earliest stages. Founded in 2018 as a joint venture between Axel Springer and Porsche, APX is known for backing digital business models and exceptional founding teams across Europe. It has invested in over 185 companies, spanning industries such as fintech, SaaS, consumer services, and mobility. APX is committed to being a long-term partner, often serving as the first investor for many startups. They typically provide initial funding up to €500,000, with follow-on support available as companies grow. In 2023, they launched HEARTFELT, a new fund focused on continuing early-stage investments while managing their existing portfolio. With a hands-on approach, APX offers not just capital but also guidance on sales, operations, and strategic partnerships. Their network of experienced investors and successful entrepreneurs plays a key role in helping startups scale.

Aqua-Spark, based in the Netherlands, is a global investment fund dedicated to sustainable aquaculture. Founded in 2013 by Mike Velings and Amy Novogratz, the fund aims to transform the aquaculture industry by promoting environmental and social sustainability alongside financial returns. Aqua-Spark's mission is to make the production of aquatic life such as fish, shellfish, and plants safe, accessible, and environmentally friendly. The fund manages around $450 million in assets and has invested in 24 companies across the aquaculture value chain, aiming to expand its portfolio to 50-60 companies. Some notable investments include eFishery, an Indonesian aquaculture tech startup, Calysta, a biotech company producing sustainable feed ingredients, and Wanda Fish, which is developing cultivated bluefin tuna. Aqua-Spark focuses on early-stage investments, typically at the Series A stage, and supports companies through to maturity. Their investments are chosen for their potential to generate significant environmental and social impacts while delivering solid financial returns. The fund has a diverse investor base of around 300 investors from over 25 countries.

marArali Ventures, founded in 2017 and based in Bangalore, India, is a venture capital firm focused on early-stage investments in enterprise tech startups. The firm primarily targets companies in India but has also invested in the United States and Singapore. Their investment strategy includes sectors such as artificial intelligence, fintech, healthtech, and high tech. Notable investments by Arali Ventures include Wingman, a conversational AI for sales, and Insent, a B2B enterprise sales platform acquired by ZoomInfo in 2021. Other significant investments include Protecto in business services and Wiz Freight in logistics tech​. Arali Ventures has made 28 investments to date and has achieved notable exits with companies like Insent and Wingman. The firm is currently raising its second seed fund, aiming for $30-40 million, to continue supporting startups in SME tech, industrial automation, and robotics​. Their team, led by Managing Partner Rajiv Raghunandan, provides extensive support to portfolio companies, emphasizing a hands-on approach and deep industry expertise. This supportive environment has made them a highly founder-friendly VC firm.

Aramco Ventures is the corporate venture capital arm of Saudi Aramco, one of the world’s largest integrated energy and chemicals companies. Established in 2012, the fund has grown significantly, recently receiving an additional $4 billion, bringing its total capital to $7.5 billion. This expansion supports Aramco's long-term strategy of investing in technologies critical to energy transition and sustainability. Aramco Ventures operates through several specialized funds, including its Prosperity7 and Sustainability Fund, focusing on sectors such as carbon management, hydrogen, renewables, AI, and advanced materials. The firm has made over 140 investments globally, backing companies like Promethean Particles and Seeq that align with its strategic goals of advancing low-carbon and innovative technologies. The fund is headquartered in Dhahran, Saudi Arabia, and led by CEO Mahdi Aladel. It actively seeks out companies that can contribute to the global energy transition, emphasizing technologies that offer scalable solutions to the challenges facing the energy sector today​.

ARAX Capital Partners, founded in 2007 and based in Vienna, Austria, is a venture capital firm that focuses on early-stage investments across the life sciences and technology sectors. They are particularly invested in Austrian ventures, targeting young, innovative companies, especially those with patentable technology. ARAX is committed to fostering the growth of startups in these fields by providing significant strategic and financial support. The firm's notable investments include Calyxha Biotechnologies, EveliQure Biotechnologies, and Panoptes Pharma, showcasing their emphasis on biotech and life sciences. Additionally, they have invested in technology companies like The MoonVision and crystalsol, a renewable energy company​​. ARAX Capital Partners generally participates in funding rounds ranging from $1 million to $9 million and has made 41 investments to date. They typically lead rounds, indicating their active role in shaping the growth trajectories of their portfolio companies​​. The team at ARAX is led by experienced partners such as Christian Tiringer, Beatrix Schuberth, and Thomas Cimbal, who bring extensive expertise in venture capital and entrepreneurship to the firm​​. This leadership helps ARAX maintain a strong network and high-quality deal flow, positioning them as a key player in Austria’s venture capital landscape. For startups, ARAX Capital Partners is a valuable partner, particularly for those in the early stages of development, looking for both capital and strategic guidance to scale their innovative solutions in the biotech and technology sectors​.

Arboretum Ventures, headquartered in Ann Arbor, Michigan, is a prominent venture capital firm specializing in the healthcare sector. Founded in 2002 by Jan Garfinkle and Tim Petersen, the firm manages $1 billion across six funds. Arboretum Ventures focuses on capital-efficient investment opportunities in medical devices, life science tools, diagnostics, tech-enabled care delivery, and pharma adjacencies​. The firm has a strong commitment to investing in under-ventured geographies, particularly in the Midwest. Their portfolio includes a variety of innovative companies such as NeuMoDx, which was acquired by QIAGEN, and Fifth Eye, known for its early warning system for patient care​. Arboretum's investment strategy emphasizes supporting startups that aim to reduce healthcare costs while improving patient outcomes. They are active partners, providing strategic guidance and leveraging their extensive network to help portfolio companies succeed. The team includes managing partners Jan Garfinkle, Dr. Tom Shehab, Dan Kidle, and other key members like Paul McCreadie and Marcy Marshall. Overall, Arboretum Ventures stands out for its proactive involvement with entrepreneurs and its focus on transformative healthcare solutions that address significant industry challenges​,

Arborview Capital is a private equity firm headquartered in Chevy Chase, Maryland, founded in 2008. The firm focuses on investing in impact-driven, high-growth companies that contribute to sustainability and resource efficiency. With a deep commitment to environmental stewardship, Arborview seeks to back companies that drive positive change across industries like energy efficiency, sustainable agriculture, water conservation, and waste reduction. Their portfolio includes standout companies like Vital Farms, TemperPack, Rachio, and Copper Cow Coffee, all recognized for pushing the boundaries of sustainability and innovation. Arborview Capital typically invests between $5 million and $15 million, engaging with companies that generate at least $5 million in revenue and have a clear path to profitability. Their investment strategy is built around creating concentrated portfolios, allowing them to take a hands-on approach and form deep, strategic partnerships with management teams. They are open to leading rounds or co-investing, and often hold board positions, ensuring active involvement in scaling their companies. Geographically, Arborview primarily invests in U.S.-based companies, though they also explore opportunities in Canada and Mexico. As a B Corp certified firm, they align their financial goals with their commitment to creating lasting environmental impact, prioritizing patient capital over quick exits. Led by co-founders Joseph Lipscomb and Karl Khoury, alongside a seasoned team, Arborview prides itself on being a values-driven firm. Their approach combines deep industry expertise with a genuine passion for sustainability, making them trusted partners for entrepreneurs looking to scale impactful businesses.

Arch Venture Partners is a powerhouse in venture capital, specializing in early-stage investments in life sciences and technology. With a notable portfolio that includes industry leaders like Grail, Illumina, and Denali Therapeutics, Arch focuses on groundbreaking innovations that transform healthcare and biotech. They have a strong geographic footprint in the United States, with significant investments also in China and the UK. Their investment strategy centers on nurturing disruptive technologies with high-impact potential. Arch Venture Partners typically leads investment rounds, deploying substantial capital to accelerate growth, evidenced by their recent $2.975 billion Fund XII. The firm prioritizes deep scientific expertise and collaborates closely with founders to guide long-term strategic development. Average check sizes vary, but their robust funding capabilities mean they often make sizable commitments. Founded in 1986, Arch is driven by a team of seasoned professionals, including co-founder Robert Nelsen, who has been instrumental in the success of numerous billion-dollar companies. The firm values direct and collaborative approaches from startups, emphasizing the importance of innovative ideas backed by solid research. Overall, Arch Venture Partners stands out for its dedication to pioneering science and technology, its active role in funding and strategy, and its impressive track record of high-profile successes.

Archetype is an early-stage venture capital firm that focuses on accelerating the decentralized future, primarily backing startups in the Web3 and cryptocurrency space. Founded in 2021 and based in New York, Archetype is led by founder Ash Egan and a team of experienced professionals from the crypto, investing, and engineering worlds. The firm invests in seed-stage companies, with check sizes typically ranging from $1M to $3M. They also lead many of their funding rounds. Archetype is known for backing founders who are disrupting traditional industries by creating entirely new markets within the decentralized economy. The firm's portfolio includes standout names like Alchemy, Socket, and Mona, all of which focus on cutting-edge technologies in crypto infrastructure, blockchain development, and decentralized applications. Archetype’s investment philosophy is centered on supporting founders with deep technical expertise and a vision for decentralization. They are highly active in the U.S., with a particular focus on startups that bring innovation to financial services, infrastructure, and software development. The firm also provides strategic guidance, leveraging its team’s extensive network within the crypto ecosystem to help startups grow from concept to market-ready products. By combining their expertise in both technology and operations, Archetype positions itself as a critical partner for crypto founders looking to build and scale innovative projects in the decentralized world.

Archimed Group, founded in 2014 and headquartered in Lyon, France, is a leading private equity firm specializing in the healthcare sector. The firm manages around €8 billion in assets and is focused on investing in small to midsize companies across seven key healthcare sectors, including Biopharma, MedTech, and Healthcare IT. Archimed’s strategy involves acquiring majority stakes in companies and working closely with them to accelerate growth, drive innovation, and expand internationally. Archimed has a strong track record, with its funds consistently ranking in the top decile for performance. The firm’s latest fund, MED Platform II, closed at €3.5 billion in 2023, making it the largest healthcare-only private equity fund raised by a European-based firm. This fund is primarily focused on mid-cap companies in Europe and North America, aiming to support healthcare leaders in scaling their operations through strategic acquisitions and capacity expansions. Archimed’s commitment to impact investing is evident through its alignment with sustainable development goals and its EURÊKA Foundation, which supports healthcare-related charitable initiatives. The firm’s unique blend of financial, medical, and operational expertise positions it as a key player in the global healthcare investment landscape.

ArcTern Ventures, a Toronto-based venture capital firm with offices in San Francisco and Oslo, is dedicated to tackling climate change through investments in breakthrough technologies. Their focus areas include renewable energy, clean mobility, the circular economy, sustainable food and agriculture, and industrial decarbonization. They manage one of the world's largest dedicated climate tech funds, recently closing their oversubscribed $335 million Fund III​. ArcTern Ventures typically invests in early growth-stage companies that show significant potential for greenhouse gas emission reductions. Their strategy is to back companies with some commercial traction, aiming for those that can rapidly scale revenue and provide immediate climate impact. They often lead investment rounds, with initial checks ranging from $5 million to $10 million, and can commit up to $35 million per company, including follow-on support​. Notable investments by ArcTern Ventures include Clir Renewables, Flashfood, Hydrostor, and Terramera. These companies exemplify ArcTern’s commitment to sustainability and innovation across North America and Europe. The firm values deep research and collaboration, partnering with bold entrepreneurs to drive significant environmental impact.